| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30076117 | HIV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS30073579 | HIV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20006164 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20009131 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20008666 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20040249 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20026966 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20045690 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS44029003 | HTLV-1 | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS44043388 | HTLV-1 | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIA3 |
|---|---|
| DrugBank ID | DB00237 |
| Drug Name | Butabarbital |
| Target ID | BE0000831 |
| UniProt ID | P42263 |
| Regulation Type | antagonist |
| PubMed IDs | 11264449; 10487207 |
| Citations | Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51.@@Krasowski MD, Harrison NL: General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci. 1999 Aug 15;55(10):1278-303. |
| Groups | Approved; Illicit |
| Direct Classification | Barbituric acid derivatives |
| SMILES | CCC(C)C1(CC)C(=O)NC(=O)NC1=O |
| Pathways | |
| PharmGKB | PA164743463 |
| ChEMBL | CHEMBL449 |
